AccuraGen China passed the proficiency test of 2019-nCoV nucleic acid testing (NCCL)
April 9, 2020
AccuraGen China passed the proficiency test of 2019-nCoV nucleic acid testing (NCCL)
The latest news
from architecture world.
Collaborative research on early detection of colorectal cancer unveiled at AGBT
February 28, 2020
AccuraGen unveil edits result of the collaborative research on the early detection of colorectal cancer at AGBT this year.
AccuraGen China passed the PT of 2019-nCoV nucleic acid testing
February 25, 2020
Shanghai Yunsheng Medical Laboratory has actively participated in the 2019-nCoV nucleic acid detection capability verification organized by SCCL
Shanghai Yunsheng Medical Laboratory joined the Inclusive Medical Association
May 14, 2018
Shanghai Yunsheng Medical Laboratory under AccuraGen Holdings participated in the launch of the Inclusive Medical Association.
Collaborator presented AccuraGen's ctDNA-NGS kit validation at AACR
April 25, 2018
The study was conducted by Professor Jiatao Lou, director of the Chest Hospital.
AccuraGen Clinical Laboratory obtained CAP accreditation
March 5, 2018
The High-throughput Sequencing (NGS) Laboratory of AccuraGen Holdings Group has been accredited by the College of American Pathologists (CAP).
AccuraGen passed the EQA of bioinformatics with full score
January 29, 2018
Shanghai Yunsheng Medical Laboratory Co., Ltd., a subsidiary of AccuraGen Holdings, passed the external quality evaluation with 100 marks.
AccuraGen was invited to PMWC to showcase the latest achievements in liquid biopsy
January 29, 2018
The Precision Medicine World Conference (PMWC) of 2018 was held in Silicon Valley from January 22 to 24 in the United States.